As mentioned by Todd Goldstein, director of design and innovation at Northwell, Yahoo Finance, “First it was the kits, then it became the reagents [in short supply], then it became the swabs. Clearly, we couldn’t print the kits or the reagents. Its tough, everyone wants the same supplies at the same time.”
This entry was posted in 3D Printing and biofabrication., 3D Printing challenges, Real estate., 3D printing for medical., 3D printing industry growth and stocks., A forum for 3D printing experts., SV3DPrinter.com policy. and tagged 3D printing and coronavirus testing, and Parts During the COVID-19 Pandemic, FAQs on 3D Printing of Medical Devices, FDA, How 3D-printing is playing a role in coronavirus testing, Northwell, Todd Goldstein, Yahoo Finance.